ASPI Sets Virtual 2025 Annual Meeting for Director Elections, Auditor Ratification
Ticker: ASPI · Form: DEF 14A · Filed: Nov 25, 2025 · CIK: 1921865
Sentiment: neutral
Topics: Proxy Statement, Corporate Governance, Director Election, Auditor Ratification, Virtual Meeting, Shareholder Vote, SEC Filing
Related Tickers: ASPI
TL;DR
**ASPI's upcoming virtual annual meeting is a routine governance check, but pay attention to director re-elections for long-term strategic stability.**
AI Summary
ASP Isotopes Inc. (ASPI) is holding its 2025 Annual Meeting of Stockholders on December 18, 2025, virtually via live webcast. The primary purposes of the meeting are to elect two Class III directors, Sipho N. Maseko and Todd Wider, M.D., for a three-year term expiring in 2028, and to ratify the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. As of the record date, October 27, 2025, there were 110,840,122 shares of common stock outstanding, with a quorum requiring approximately 55,420,062 shares. The company emphasizes expanded stockholder access and participation through the virtual format. The filing does not contain specific financial figures for revenue or net income, focusing instead on corporate governance and procedural matters for the upcoming annual meeting. Risks are not explicitly detailed beyond general voting procedures and technical access for the virtual meeting.
Why It Matters
This DEF 14A filing outlines the critical governance decisions for ASP Isotopes Inc., directly impacting investor confidence through board composition and financial oversight. The re-election of Class III directors Sipho N. Maseko and Todd Wider, M.D., will shape the company's strategic direction for the next three years, while the ratification of EisnerAmper LLP ensures continued independent financial scrutiny. For investors, these votes are crucial for maintaining accountability and transparency, especially in a competitive market where strong governance can differentiate companies. Employees and customers benefit from a stable, well-governed company, though the direct impact on them is less immediate than for shareholders.
Risk Assessment
Risk Level: low — The filing primarily details procedural aspects of an annual meeting, including director elections and auditor ratification, which are standard corporate governance items. There are no indications of significant financial distress, regulatory non-compliance, or contentious proposals. The virtual meeting format is designed to enhance access, mitigating risks associated with physical attendance.
Analyst Insight
Investors should review the backgrounds of Sipho N. Maseko and Todd Wider, M.D., to ensure their qualifications align with ASPI's strategic goals. Ratifying EisnerAmper LLP is a routine vote, but shareholders should confirm the firm's independence. Vote your proxy to ensure your voice is heard on these governance matters.
Key Numbers
- 110,840,122 — Shares of common stock outstanding (As of the record date, October 27, 2025, determining voting power.)
- 55,420,062 — Shares for quorum (Represents a majority of outstanding shares required to conduct business at the Annual Meeting.)
- 2 — Class III directors to be elected (Sipho N. Maseko and Todd Wider, M.D., for a three-year term until 2028.)
- 2025-12-18 — Annual Meeting Date (Date of the virtual Annual Meeting of Stockholders.)
- 2025-10-27 — Record Date (Date for determining stockholders entitled to vote at the Annual Meeting.)
- 2028 — Director term expiration year (Class III directors will serve until the 2028 annual meeting.)
- 7 — Total Board members (Current composition of the ASP Isotopes Inc. Board of Directors.)
- 6 — Independent Board members (Number of directors deemed 'independent' under Nasdaq listing standards.)
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant and Company for the DEF 14A filing
- EisnerAmper LLP (company) — Independent registered public accounting firm for fiscal year ending December 31, 2025
- Sipho N. Maseko (person) — Nominee for Class III director until 2028
- Todd Wider, M.D. (person) — Nominee for Class III director until 2028
- Paul E. Mann (person) — Executive Chairman of the Board
- SEC (regulator) — United States Securities and Exchange Commission
- Nasdaq Stock Market LLC (regulator) — Listing standards for independent directors
- Equiniti Trust Company, LLC (company) — Registrar and transfer agent
- 110,840,122 (dollar_amount) — Shares of common stock outstanding as of October 27, 2025
- 55,420,062 (dollar_amount) — Shares required for a quorum at the Annual Meeting
FAQ
What is the purpose of ASP Isotopes Inc.'s 2025 Annual Meeting?
The 2025 Annual Meeting of ASP Isotopes Inc. is being held to elect two Class III directors, Sipho N. Maseko and Todd Wider, M.D., for a three-year term until the 2028 annual meeting, and to ratify the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
When and where will the ASP Isotopes Inc. Annual Meeting be held?
The Annual Meeting of Stockholders for ASP Isotopes Inc. will be held on Thursday, December 18, 2025, at 10:00 a.m., Eastern time. It will be a virtual meeting accessible via live webcast over the Internet at https://meetings.lumiconnect.com/200-529-383-259.
Who are the Class III directors nominated for re-election at ASPI's 2025 Annual Meeting?
The two Class III directors nominated for re-election at ASP Isotopes Inc.'s 2025 Annual Meeting are Sipho N. Maseko and Todd Wider, M.D. They are nominated to serve a three-year term until the 2028 annual meeting of stockholders.
What is the record date for voting at ASP Isotopes Inc.'s 2025 Annual Meeting?
The record date for determining stockholders entitled to notice of and to vote at ASP Isotopes Inc.'s 2025 Annual Meeting is the close of business on October 27, 2025. Only stockholders owning shares on this date can vote.
How many shares of common stock were outstanding for ASP Isotopes Inc. as of the record date?
As of the record date, October 27, 2025, there were 110,840,122 shares of ASP Isotopes Inc. common stock outstanding. Each share entitles the holder to one vote at the Annual Meeting.
What accounting firm is ASP Isotopes Inc. proposing to ratify for 2025?
ASP Isotopes Inc. is proposing to ratify the appointment of EisnerAmper LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025. This is Proposal 2 on the proxy statement.
What is a 'broker non-vote' and how does it affect ASPI's proposals?
A 'broker non-vote' occurs when a broker holding shares for a beneficial owner does not receive voting instructions and lacks discretionary authority to vote on a non-routine matter. For ASPI's director election (non-routine), broker non-votes will not be counted as votes cast and will have no effect. However, auditor ratification is a routine matter, so broker non-votes are unlikely for that proposal.
How can a beneficial owner vote at ASP Isotopes Inc.'s virtual Annual Meeting?
Beneficial owners must register in advance by obtaining a legal proxy from their broker, bank, or nominee and submitting it to Equiniti by 5 p.m. ET on December 1, 2025, to receive an 11-digit control number. This control number is then used to access the virtual meeting site and vote.
What is the quorum requirement for ASP Isotopes Inc.'s 2025 Annual Meeting?
A quorum for ASP Isotopes Inc.'s 2025 Annual Meeting requires the presence, in person or by proxy, of holders representing a majority of the outstanding shares of common stock as of October 27, 2025. This amounts to approximately 55,420,062 shares.
How will ASP Isotopes Inc. announce the voting results of the Annual Meeting?
ASP Isotopes Inc. will announce preliminary voting results at the Annual Meeting. Final voting results will be published in a current report on Form 8-K filed with the SEC within four business days after the Annual Meeting. If final results are delayed, a preliminary Form 8-K will be filed, followed by an additional Form 8-K with final results.
Industry Context
ASP Isotopes Inc. operates in the specialized field of isotope production. The company's focus is on developing and commercializing isotopes for medical and industrial applications. The competitive landscape involves other specialized chemical and materials science companies, with barriers to entry including technological expertise, regulatory hurdles, and capital investment.
Regulatory Implications
The primary regulatory aspect highlighted is the ratification of the independent auditor, EisnerAmper LLP, which is standard practice and crucial for financial reporting compliance. The virtual meeting format also implies adherence to regulations governing stockholder communication and participation in corporate governance.
What Investors Should Do
- Review the nominees for Class III director positions (Sipho N. Maseko and Todd Wider, M.D.) and vote accordingly to ensure board continuity and expertise.
- Vote to ratify the appointment of EisnerAmper LLP as the independent registered public accounting firm to maintain financial transparency and compliance.
- Participate in the virtual Annual Meeting on December 18, 2025, to exercise voting rights and engage with management, leveraging the expanded access provided by the online format.
Key Dates
- 2025-12-18: 2025 Annual Meeting of Stockholders — Key date for electing directors and ratifying auditor appointment. Virtual format aims for expanded stockholder access and participation.
- 2025-10-27: Record Date — Determines which stockholders are entitled to vote at the Annual Meeting. 110,840,122 shares of common stock were outstanding on this date.
- 2028: Director Term Expiration — The newly elected Class III directors, Sipho N. Maseko and Todd Wider, M.D., will serve until this year, indicating a three-year term.
- 2024-12-31: Fiscal Year End — The independent registered public accounting firm is being ratified for the fiscal year ending on this date.
- 2025-12-01: Mailing of Proxy Materials — Indicates when stockholders will receive the proxy statement and annual report, allowing time for review before the meeting.
Glossary
- DEF 14A
- A proxy statement filing required by the SEC for annual meetings of stockholders. (This document is the DEF 14A filing for ASP Isotopes Inc.'s 2025 Annual Meeting.)
- Class III directors
- Directors who are elected for a staggered three-year term. (Two Class III directors are up for election at the 2025 Annual Meeting.)
- Quorum
- The minimum number of shares required to be present (in person or by proxy) for a stockholders' meeting to be valid. (A quorum requires approximately 55,420,062 shares, representing a majority of the 110,840,122 outstanding shares.)
- Independent registered public accounting firm
- An external audit firm that meets specific independence requirements to audit a company's financial statements. (EisnerAmper LLP is proposed for ratification as the company's auditor for the fiscal year ending December 31, 2025.)
- Virtual format
- A meeting conducted online, typically via a live webcast, rather than in a physical location. (The 2025 Annual Meeting will be held virtually to enhance stockholder access and participation.)
Year-Over-Year Comparison
This filing is for the 2025 Annual Meeting and focuses on procedural matters like director elections and auditor ratification. It does not provide comparative financial data against a prior year's filing within the provided text. Key numbers relate to the current meeting's record date and quorum requirements, not year-over-year financial performance trends.
Filing Stats: 4,860 words · 19 min read · ~16 pages · Grade level 11.3 · Accepted 2025-11-25 16:33:19
Filing Documents
- aspi_def14a.htm (DEF 14A) — 352KB
- aspi_def14aimg17.jpg (GRAPHIC) — 6KB
- aspi_def14aimg18.jpg (GRAPHIC) — 155KB
- aspi_def14aimg19.jpg (GRAPHIC) — 121KB
- aspi_def14aimg20.jpg (GRAPHIC) — 218KB
- aspi_def14aimg7.jpg (GRAPHIC) — 4KB
- 0001477932-25-008604.txt ( ) — 1046KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 18 EXECUTIVE OFFICERS 20
EXECUTIVE COMPENSATION AND OTHER INFORMATION
EXECUTIVE COMPENSATION AND OTHER INFORMATION 21 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 28 DELINQUENT SECTION 16(a) REPORTS 29 STOCKHOLDER PROPOSALS 29 STOCKHOLDERS SHARING THE SAME ADDRESS 30 OTHER MATTERS 30 601 Pennsylvania Avenue NW, South Building, Suite 900 Washington, DC 20004 PROXY STATEMENT FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS To Be Held on Thursday, December 18, 2025 The board of directors (the "Board") of ASP Isotopes Inc. (the "Company" or "ASPI") is soliciting proxies for use at the 2025 Annual Meeting of Stockholders (the "Annual Meeting") to be held on Thursday, December 18, 2025, at 10:00 a.m., Eastern time, and any postponements or adjournments thereof. The Annual Meeting will be held in a virtual format only, via live webcast over the Internet. You will be able to join the Annual Meeting and vote and submit your questions online during the Annual Meeting by visiting https://meetings.lumiconnect.com/200-529-383-259 . We have designed the virtual Annual Meeting to ensure that stockholders are afforded the same opportunity to participate as they would have at an in-person meeting, including the right to vote and ask questions through the virtual meeting platform. Reference to "in person" attendance or voting in our proxy materials refers, therefore, to attending or voting at the Annual Meeting virtually. GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING Why did I receive these proxy materials? We have furnished these proxy materials to you because our Board is soliciting your proxy to vote at the Annual Meeting. This proxy statement summarizes information related to your vote at the Annual Meeting. All stockholders are cordially invited to attend the Annual Meeting. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may simply complete and submit your proxy via phone or the Internet in accordance with the instructions provided in this proxy statement or on